Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma
- PMID: 25156647
- DOI: 10.1016/j.jvir.2014.06.028
Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma
Abstract
Purpose: To characterize the distribution of absorbed radiation dose after glass microsphere radioembolization for hepatocellular carcinoma (HCC) using yttrium-90 ((90)Y) positron emission tomography/computed tomography (PET/CT).
Materials and methods: In this retrospective study, 64 (90)Y PET/CT scans performed after treatment were evaluated following (90)Y glass-bead radioembolization in patients with advanced HCC. The intended dose to the target volume ranged from 83-129 Gy. Three-dimensional "dose maps" were created from reconstructed PET images using a voxel-based S-value transformation. Liver parenchyma and liver tumors were contoured on cross-sectional imaging and aligned with the created dose maps.
Results: There were 113 tumors examined as part of 64 lobar treatments. The average tumor size was 4.8 cm ± 4.0 with an average tumor dose of 173 Gy ± 109. The average dose to the nontumor parenchyma within the target volume was 93.4 Gy ± 32.6, with on average 50% of the parenchymal voxels receiving > 79 Gy ± 23 and 10% receiving > 173 Gy ± 55. The average and median tumor-to-parenchymal weighted dose ratios were 2.2 and 1.9, respectively.
Conclusions: Using recommended dosimetry and administration techniques for lobar glass microsphere radioembolization, high doses to target tumors as well as background parenchyma were achieved on average with modest preferential uptake within tumors. There was wide variation in measured tumor and parenchymal doses after hepatic radioembolization for HCC, suggesting the need for continued development of patient-specific dosimetry.
Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.
Similar articles
-
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007. J Vasc Interv Radiol. 2014. PMID: 24461133
-
Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.J Vasc Interv Radiol. 2013 Aug;24(8):1147-53. doi: 10.1016/j.jvir.2013.04.018. Epub 2013 Jun 20. J Vasc Interv Radiol. 2013. PMID: 23792126
-
Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.J Vasc Interv Radiol. 2014 Feb;25(2):288-95. doi: 10.1016/j.jvir.2013.08.021. Epub 2013 Oct 23. J Vasc Interv Radiol. 2014. PMID: 24269792
-
[Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].Rofo. 2010 Aug;182(8):660-70. doi: 10.1055/s-0029-1245380. Epub 2010 Apr 19. Rofo. 2010. PMID: 20405369 Review. German.
-
Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review.J Vasc Interv Radiol. 2012 May;23(5):669-74. doi: 10.1016/j.jvir.2012.01.059. J Vasc Interv Radiol. 2012. PMID: 22525023 Review.
Cited by
-
Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC.EJNMMI Res. 2022 Feb 4;12(1):9. doi: 10.1186/s13550-022-00879-x. EJNMMI Res. 2022. PMID: 35122166 Free PMC article.
-
Effects of Respiratory Motion on Y-90 PET Dosimetry for SIRT.Diagnostics (Basel). 2022 Jan 14;12(1):194. doi: 10.3390/diagnostics12010194. Diagnostics (Basel). 2022. PMID: 35054361 Free PMC article.
-
Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters.Front Oncol. 2021 Oct 5;11:592529. doi: 10.3389/fonc.2021.592529. eCollection 2021. Front Oncol. 2021. PMID: 34676157 Free PMC article.
-
Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model.J Vasc Interv Radiol. 2021 Jan;32(1):23-32.e1. doi: 10.1016/j.jvir.2020.09.016. Epub 2020 Nov 12. J Vasc Interv Radiol. 2021. PMID: 33189539 Free PMC article.
-
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres.Cardiovasc Intervent Radiol. 2020 Sep;43(9):1378-1383. doi: 10.1007/s00270-020-02504-7. Epub 2020 May 20. Cardiovasc Intervent Radiol. 2020. PMID: 32435831 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical